CoChat

Pericyte implantation in the brain enhances cerebral blood flow and reduces amyloid-β pathology in amyloid model mice

Open access
Tachibana, Masaya, Yamazaki, Yu, Liu, Chia-Chen, Bu, Guojun, Kanekiyo, Takahisa · 2018 · Experimental Neurology
Cited by 91

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Abstract

Pericytes are a major component of cerebrovasculature playing a key role in maintaining cerebrovascular homeostasis. These cells have also been suggested to regulate brain metabolism of amyloid‐&bgr; (A&bgr;), disturbances of which are believed to contribute to the pathogenesis of Alzheimer's disease (AD). To examine the effects of pericytes on brain A&bgr; metabolism, C3H/10T1/2 mouse mesenchymal stem cells were differentiated into pericytes and stereotaxically injected into the brains of amyloid AD model APP/PS1 mice at the age of 18 to 20 months. Consistent with a role of pericytes in modulating cerebrovascular function, brain microcirculation in the pericyte‐injected hemisphere of the mice was increased 3 weeks after implantation compared to the contralateral hemisphere when measured by laser speckle contrast analysis technology. Importantly, enzyme‐linked immunosorbent assay revealed that the levels of insoluble A&bgr;40 and A&bgr;42 were significantly lower in the hippocampus of the pericyte‐injected hemisphere of the APP/PS1 mice than that of the contralateral side. Consistently, immunohistochemical analysis demonstrated that the pericyte implantation reduced A&bgr; deposition in the hippocampus. When brain slices from the APP/PS1 mice were incubated with C3H/10T1/2 cell‐derived pericytes, A&bgr;42 levels were significantly reduced in a manner that depends on the expression of a major A&bgr; endocytic receptor, the low‐density lipoprotein receptor‐related protein 1 (LRP1). While LRP1 mediated the cellular uptake of A&bgr; in the pericytes, the amounts of major A&bgr;‐degrading enzymes were not affected by LRP1 knockdown. Together, our findings indicate that mesenchymal stem cell–derived pericytes have the capacity to reduce brain A&bgr; and related pathology, and suggest that cell‐based therapy through transplantation of pericytes may be a promising approach to prevent and/or treat AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.expneurol.2017.10.023

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 32 references

Cited by

See all 91

Metadata

Authors
Tachibana, M., Yamazaki, Y., Liu, C.-C., Bu, G., & Kanekiyo, T.
Venue
Experimental Neurology
Publisher
Elsevier BV
Published
2018-02
Volume
300
Pages
13-21
ISSN
0014-4886 (ISSN-L)
OpenAlex
W2765772215
Cited by
91
References
32
FWCI
3.78
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pericyte implantation in the brain enhances cerebral blood flow and reduces amyloid-β pathology in amyloid model mice. https://app.cochat.ai/papers/10.1016/j.expneurol.2017.10.023
The paper
Tachibana, M., Yamazaki, Y., Liu, C.-C., Bu, G., & Kanekiyo, T. (2018). Pericyte implantation in the brain enhances cerebral blood flow and reduces amyloid-β pathology in amyloid model mice. Experimental Neurology. https://doi.org/10.1016/j.expneurol.2017.10.023

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.